Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

The $50 billion investment in the United States by AstraZeneca is just one of many significant investments expected from pharmaceutical companies as they react to President Donald Trump’s ...

AstraZeneca is investing $50 billion in U.S. manufacturing and research by 2030, with a focus on producing drug substances for chronic disease treatments. The main element of the investment is a ...

Treasury Secretary Scott Bessent offered support for Jerome Powell amid regular attacks from Trump administration officials, ...

NEW YORK (AP) — Amid a federal overhaul of student loan plans, many borrowers have been left wondering what it means for ...

AstraZeneca plans a $50 billion investment to expand its US manufacturing and research capacity by 2030, driven by tariff ...

AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

WASHINGTON (AP) — OpenAI CEO Sam Altman warned the financial industry of a “significant impending fraud crisis” because of ...

President Donald Trump referenced the announcement the following day in Oval Office remarks, framing AstraZeneca’s overall ...

AstraZeneca has announced plans to invest $50 billion in the U.S. by 2030 amid concerns over tariffs. The British pharmaceutical company said its investment would fund a new drug manufacturing ...